期刊文献+

乙肝病毒表面抗原阳性孕妇产前病毒感染状态分析 被引量:3

Analysis of the HBV infection status in HBsAg positive pregnant women prior to their delivery
下载PDF
导出
摘要 目的了解乙肝病毒表面抗原(HBsAg)阳性孕妇中乙肝病毒(HBV)感染相关指标分布特征,以评价HBV母婴阻断失败高危因素的分布强度及影响因素。方法采用现况调查方法,对2009年8月-2010年12月期间入选的895名HBsAg阳性孕妇进行人口学信息、与HBV感染相关的信息调查,采集血液样品检测HBsAg、HBeAg、抗-HBe及HBV DNA滴度等指标,并对结果进行统计分析。结果 HBsAg阳性孕妇产前HBeAg阳性率为33.4%,HBV DNA载量>107IU/ml者占25.2%,HBsAg滴度≥10 000IU/mL者占29.61%;HBeAg阳性者中,HBsAg滴度与HBV DNA载量间存在密切正相关关系(r=0.53,P<0.01);随孕妇年龄的增加,孕妇产前HBeAg阳性率和HBV DNA载量均有明显降低趋势。结论 HB-sAg阳性孕妇中存在母婴阻断失败高危险因素的比例较高。适当推迟怀孕年龄,可降低HBsAg阳性人群HBV母婴阻断失败的风险。 Objective To explore the distribution of HBV infection biomarkers in HBsAg positive pregnant women, and an alyze the causes of this distribution. Methods From Aug. 2009 to Nov. 2010, a structured questionnaire on demographic data was administered to eight hundred and ninety five HBsAg positive pregnant women, from whom blood samples were then col lected to test for HBsAg, HBeAg, Anti HBe and HBV DNA. The collected data were analyzed by SPSS software. ResultsOf the 895 subjects, 33.4% were HBeAgpositive, and 25.2% had HBV DNA levels of 107 IU/mL. Among HBeAg positive pregnant women, HBsAg titers were positively correlated with HBV DNA level (r= 0. 53,P〈0. 01). There was a trend of decreased risk of mothertoinfant transmission with the increasing age. Conclusion In Chinese HBsAgpositive pregnant women, risk of HBV mothertoinfant transmission is relatively high, and delaying the age of pregnancy may low er the risk of HBV mothertoinfant transmission.
出处 《江苏预防医学》 CAS 2012年第6期17-19,共3页 Jiangsu Journal of Preventive Medicine
基金 传染病科技重大专项(2012ZX10002-001 2011ZX10004-902)
关键词 乙型肝炎病毒 孕妇 母婴阻断 危险因素 阳性率 HBsAg pregnant women block mother- to- infant transmission risk Sactor positive rate
  • 相关文献

参考文献8

二级参考文献26

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2李雅娟,庄辉,李杰,董庆鸣,陈雅洁,牛俊奇,马为民,赵伟,赵保安,钟金群.乙型肝炎病毒感染者病毒基因型和亚型分布及其临床意义[J].中华肝脏病杂志,2005,13(10):724-729. 被引量:74
  • 32009中国卫生统计年鉴[M/OL].[2010-08-15].http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2009/t-13.htm.
  • 4World Health Organization. Hepatitis B [J/OL]. http:// www.who int/csr/disease/hepatitis/whocdscsrlyo20022/en.
  • 5中华人民共和国卫生部.2006-2010年全国乙型病毒性肝炎防治规划[Z].2006.
  • 6Kew MC. Epidemiology of chronic hepatitis B virus infec- tion,hepatocellular carcinoma,and hepatitis B virus-in- duced hepatocellular carcinoma [J]. Pathol Biol(Paris), 2010,58(4) :273-277.
  • 7McMahon BJ. The natural history of chronic hepatitis B virus infection [ J ]. Hepatology, 2009,49 ( 5suppl ) : S45-55.
  • 8Su FH,Cheng SH,Li CY,et al. Hepatitis B seropreva- lence and anamnestic response amongst Taiwan Residents young adults with full vaccination in infancy,20 years subse- quent to national hepatitis B vaccination [J]. Vaccine, 2007,25 (47) : 8085-8090.
  • 9World Health Organization. Hepatitis B vaccines[J ].Wkly Epidemid Rec,2009,84(40) :405-419.
  • 10Shepard CW,Simard EP,Finelli L,et al. Hepatitis B virus infection:epidemiology and vaccination[J]. Epidemiol Rev, 2006,25:112-125.

共引文献54

同被引文献25

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部